International audience
-
January 2022 (v1)Journal articleUploaded on: December 3, 2022
-
January 2022 (v1)Journal article
International audience
Uploaded on: December 3, 2022 -
January 2022 (v1)Journal article
International audience
Uploaded on: February 22, 2023 -
March 2018 (v1)Journal articleExpression level of GRP78/BiP as a predictor of favorable or unfavorable outcomes in cancer patients
International audience
Uploaded on: December 4, 2022 -
2021 (v1)Journal article
Biguanide is a unique chemical function, which has attracted much attention a century ago and is showing resurgent interest in recent years after a long period of dormancy. This class of compounds has found broad applications such as reaction catalysts, organic strong bases, ligands for metal complexation, or versatile starting materials in...
Uploaded on: December 4, 2022 -
September 16, 2016 (v1)Journal article
Marine bacteria produce highly cytotoxic polyheterocyclic cyclopeptide natural products by ribosomal peptide biosynthesis. Among them, urukthapelstatin A features a chain of five 2,4′-connected azole rings within a cyclo-octapeptide framework. We report a novel synthesis design that uses only α-amino acids as starting materials that leads to an...
Uploaded on: February 28, 2023 -
November 30, 2016 (v1)Journal article
DNA inevitably undergoes a high number of damages throughout the cell cycle. To preserve the integrity of the genome, cells have developed a complex enzymatic machinery aimed at sensing and repairing DNA lesions, pausing the cell cycle to provide more time to repair, or induce apoptosis if damages are too severe. This so-called DNA-damage...
Uploaded on: February 28, 2023 -
October 19, 2016 (v1)Journal article
In cancers, hypoxia inducible factor 1 (HIF-1) is an over-expressed transcription factor, which regulates a large set of genes involved in tumour vascularization, metastases, and cancer stem cells (CSCs) formation and self-renewal. This protein has been identified as a relevant target in oncology and several HIF-1 modulators are now marketed or...
Uploaded on: February 28, 2023 -
November 2021 (v1)Journal article
International audience
Uploaded on: December 3, 2022 -
August 29, 2016 (v1)Journal article
Melanoma is the deadliest form of skin cancer. While associated survival prognosis is good when diagnosed early, it dramatically drops when melanoma progresses into its metastatic form. Prior to 2011, the favored therapies include interleukin-2 and chemotherapies, regardless of their low efficiency and their toxicity. Following key biological...
Uploaded on: February 28, 2023 -
July 23, 2019 (v1)Journal article
Analogs of the natural product urukthapelstatin A that belongs to the rare family of polyazole cyclopeptides were synthesized and their cytotoxic activities were determined to gather data toward structure-activity relationships. Crucial steps within the convergent syntheses were a macrothiolacton-ization and a subsequent aza-Wittig reaction to...
Uploaded on: December 4, 2022 -
May 15, 2017 (v1)Journal article
We recently described a new family of bioactive molecules with interesting anti-cancer activities: the N-(4-(3-aminophenyl)thiazol-2-yl)acetamides. The lead compound of the series (1) displays significant anti-proliferative and cytotoxic activities against a panel of cancer cell lines, either sensitive or resistant to standard treatments. This...
Uploaded on: February 28, 2023 -
July 12, 2021 (v1)Journal article
Four novel arylbiamidine series were studied showing particular tautomerism and H-bonding structure highlighting their promising druglike features toward anticancer applications.
Uploaded on: February 22, 2023 -
July 12, 2021 (v1)Journal article
Four novel arylbiamidine series were studied showing particular tautomerism and H-bonding structure highlighting their promising druglike features toward anticancer applications.
Uploaded on: December 4, 2022 -
July 12, 2021 (v1)Journal article
Four novel arylbiamidine series were studied showing particular tautomerism and H-bonding structure highlighting their promising druglike features toward anticancer applications.
Uploaded on: December 4, 2022 -
August 30, 2016 (v1)Journal article
Cancer is the second cause of deaths worldwide and is forecasted to affect more that 22 million people in 2020. Despite dramatic improvement in its care over the last two decades, the treatment of resistant forms of cancer is still an unmet challenge. Thus, innovative and efficient treatments are still needed. In this context, we report herein...
Uploaded on: February 28, 2023 -
2020 (v1)Journal article
Two series of compounds carrying 3-amino-1,2,4-triazole scaffold were synthesized and evaluated for their anticancer activity against a panel of cancer cell lines using XTT assay. The 1,2,4-triazole synthesis was revisited for the first series of pyridyl derivatives. The biological results revealed the efficiency of the 3-amino-1,2,4triazole...
Uploaded on: December 3, 2022 -
July 15, 2021 (v1)Journal article
Abstract Overcoming acquired drug resistance is a primary challenge in cancer treatment. Notably, more than 50% of patients with BRAFV600E cutaneous metastatic melanoma (CMM) eventually develop resistance to BRAF inhibitors. Resistant cells undergo metabolic reprogramming that profoundly influences therapeutic response and promotes tumor...
Uploaded on: December 3, 2022 -
July 2021 (v1)Journal article
Background: In line with our recent discovery of an efficient anticancer thiazolebenzenesulfonamide framework HA15 (1) based on a remarkable endoplasmic reticulum stress inducement mode of action, we report herein a series of innovative constrained HA15 analogs, featuring four types of bicylic derivatives. Results: The structure–activity...
Uploaded on: December 4, 2022 -
2021 (v1)Journal article
The chemokine receptors CXCR1/2 play a key role in the aggressiveness of several types of cancers including head and neck squamous cell carcinomas (HNSCCs). In HNSCCs, CXCR1/2 signaling promotes cell proliferation and angiogenesis leading to tumor growth and metastasis. The competitive inhibitor of CXCR1/2, C29, inhibits the growth of...
Uploaded on: October 13, 2023 -
December 2022 (v1)Journal article
Medulloblastoma (MB) is the most common and aggressive paediatric brain tumour. Although the cure rate can be as high as 70%, current treatments (surgery, radio- and chemotherapy) excessively affect the patients' quality of life. Relapses cannot be controlled by conventional or targeted treatments and are usually fatal. The strong heterogeneity...
Uploaded on: February 22, 2023